Phospho-PER2 (S662) Antibody

What is the role of PER2 in the circadian rhythm?

PER2 functions as a transcriptional repressor and forms a core component of the mammalian circadian clock. This internal time-keeping system regulates various physiological processes through approximately 24-hour rhythms in gene expression, which translate into rhythms in metabolism and behavior. PER2 is primarily found in the nuclear fraction of cells where its abundance is associated with circadian period length . It participates in a negative feedback loop that helps maintain precise timing of the circadian oscillator. Studies with transgenic mice have demonstrated that the nuclear abundance of PER2 directly correlates with circadian period length, confirming its central importance to clock function .

Why is phosphorylation at S662 important for PER2 function?

Phosphorylation at serine 662 (S662) represents a critical regulatory event for PER2 function. S662 is the first serine in a highly conserved SxxSxxSxxSxxS motif found in mammalian PER proteins . When S662 is phosphorylated, it enables a cascade of phosphorylation events at downstream sites (S665, S668, S671, and S674) by Casein Kinase 1 (CK1) . This phosphorylation cascade significantly affects PER2 stability, nuclear abundance, and transcriptional repressor activity. Research indicates that the phosphorylation state of S662 correlates with PER2 nuclear abundance - when S662 is phosphorylated (as in S662D phosphomimetic mutants), PER2 shows higher nuclear abundance and increased phosphorylation, suggesting enhanced stability . When S662 phosphorylation is prevented (as in the S662G mutation), PER2 exhibits reduced phosphorylation and lower nuclear abundance, affecting the circadian period .

How does the phosphoswitch mechanism regulate PER2 stability?

The PER2 protein is regulated by a sophisticated phosphoswitch mechanism where CK1δ/ε can phosphorylate either of two competing sites: S662 or S480. This mechanism plays a crucial role in determining PER2 stability and subsequently circadian period . Phosphorylation at S480 facilitates PER2 interaction with β-TrCP, leading to ubiquitination and proteasomal degradation . In contrast, phosphorylation at S662 initiates a cascade of phosphorylation events that enhances PER2 stability and nuclear abundance .

Mathematical modeling of this phosphoswitch accurately reproduces the unusual kinetics of PER2 degradation, where PER2 degradation curves contain a plateau phase during accumulation . The model successfully simulates experimental observations including the negligible period change in CK1ε−/− mutant mice, longer period in CK1δ−/− mutant mice, and shorter period in FASP (S662G) humans and mice .

What is the interplay between different post-translational modifications of PER2?

PER2 undergoes multiple post-translational modifications (PTMs) that collectively regulate its function, including phosphorylation, SUMOylation, acetylation, and ubiquitination. These modifications form a complex regulatory network that fine-tunes PER2's role in circadian rhythm regulation.

SUMOylation of PER2 can occur with either SUMO1 or SUMO2, with different functional outcomes: SUMO2 conjugation facilitates PER2 interaction with β-TrCP, leading to proteasomal degradation, while SUMO1 conjugation enhances CK1-mediated PER2 stability . Acetylation of PER2 at lysine residues protects it from ubiquitination, whereas deacetylation by SIRT1 promotes degradation .

The phosphorylation status at S662 may influence the accessibility of lysine residues for acetylation or SUMOylation, while these modifications may in turn affect the recognition of PER2 by kinases or phosphatases. This complex interplay allows for precise regulation of PER2 levels and activity throughout the circadian cycle and in response to various cellular signals.

How can you interpret changes in PER2 phosphorylation patterns across different circadian time points?

PER2 typically exhibits circadian-dependent electrophoretic mobility shifts due to phosphorylation, with higher molecular weight bands indicating increased phosphorylation . In wild-type conditions, S662WT and S662D mice show mobility shifts beginning at CT12, while S662G mice display maximal phosphorylation levels at CT20 . The intensity of mobility-shifted bands in S662WT is intermediate between those in S662G and S662D, particularly after CT12, consistent with biochemical data showing that phosphorylation of downstream residues is modulated by S662 phosphorylation state .

When analyzing phosphorylation patterns, consider that S662 phosphorylation initiates a cascade affecting downstream sites. Therefore, changes in S662 phosphorylation should precede more extensive mobility shifts representing multi-site phosphorylation. Additionally, since phosphorylated PER2 is predominantly nuclear, correlate phosphorylation patterns with subcellular localization data to understand regulatory mechanisms .

What are the optimal conditions for using Phospho-PER2 (S662) Antibody in experimental applications?

For optimal results when using Phospho-PER2 (S662) Antibody, follow these methodological guidelines:

Sample preparation is critical: extract nuclear fractions from tissues or cells, as PER2 is predominantly nuclear . Include phosphatase inhibitors (e.g., sodium vanadate) in lysis buffers to preserve phosphorylation status . For controls, include positive controls (samples known to contain phosphorylated PER2), negative controls (samples treated with phosphatase), and specificity controls (samples expressing PER2 S662A mutant) .

Time point selection is also crucial since PER2 phosphorylation varies throughout the circadian cycle. To verify that mobility shifts are due to phosphorylation, perform parallel experiments with samples treated with protein phosphatase 2A (PP2A) with and without phosphatase inhibitors .

How can you validate the specificity of Phospho-PER2 (S662) Antibody?

Validating the specificity of Phospho-PER2 (S662) Antibody requires multiple complementary approaches:

The antibody should be tested against peptide competition assays using the immunizing peptide (derived from human Period Circadian Protein 2 around the phosphorylation site of Ser662 at amino acid range 636-685) . The antiserum is highly selective for immobilized pS662-FASP peptide, recognizing the peptide even at a dilution of 1:32,000 .

Phosphatase treatment provides another validation approach. Treatment of lysates with alkaline phosphatase should specifically decrease binding of the pS662-PER2 antibody, confirming phosphorylation dependency . Additionally, the antibody should recognize pS662, but not S662A, in full-length and truncated PER2 in immunoblots .

For definitive validation, compare antibody reactivity between wild-type PER2 and S662G mutant (which cannot be phosphorylated at this site). The antibody should recognize wild-type but not the S662G mutant protein.

What strategies can be used to study the functional consequences of PER2 S662 phosphorylation in circadian rhythm research?

To investigate the functional consequences of PER2 S662 phosphorylation in circadian rhythm research, consider these methodological approaches:

• Genetic models: Utilize transgenic mice carrying modifications at S662, such as the S662G mutation that recapitulates human FASPS, or the phosphomimetic S662D mutation . These models allow direct assessment of how S662 phosphorylation affects circadian period and behavior in vivo.

• Cellular models: Establish fibroblast cultures from skin biopsies of transgenic mice or FASPS individuals to study cell-autonomous effects of S662 phosphorylation . After synchronization by serum shock, monitor PER2 levels and phosphorylation status across time points.

• Pharmacological manipulation: Use specific CK1δ/ε inhibitors to modulate S662 phosphorylation and observe effects on circadian parameters. Combining these inhibitors with genetic models can reveal interactions between kinase activity and phosphorylation sites.

• Protein-protein interaction studies: Investigate how S662 phosphorylation affects PER2 interactions with other clock components using co-immunoprecipitation or proximity ligation assays. This approach can uncover mechanisms by which phosphorylation influences clock function.

• Mathematical modeling: Incorporate experimental data into mathematical models of the phosphoswitch mechanism to predict how alterations in S662 phosphorylation affect circadian period under various conditions .

How can you distinguish between effects on PER2 phosphorylation versus effects on total PER2 levels?

Distinguishing between direct effects on PER2 phosphorylation and effects on total PER2 levels is methodologically challenging but critical for understanding circadian regulation mechanisms:

Always probe membranes with both phospho-specific (Phospho-PER2 (S662)) and total PER2 antibodies, calculating the ratio of phosphorylated to total PER2 to normalize for abundance changes . Use pulse-chase experiments with protein synthesis inhibitors (e.g., cycloheximide) to block new PER2 synthesis and track changes in existing PER2 phosphorylation status over time.

Immunoprecipitate PER2 and perform in vitro phosphorylation with purified kinases to isolate the phosphorylation process from factors affecting protein abundance . This approach was used to demonstrate that CK1δ1 can phosphorylate the FASP priming site of PER2 in full-length protein .

Proteasome inhibition experiments can help determine whether phosphorylation precedes and causes degradation. Compare S662D (phosphomimetic) and S662G (phosphodeficient) mutants to assess whether these mutations affect protein stability independent of actual phosphorylation .

What could cause discrepancies between expected and observed PER2 phosphorylation patterns?

Several factors can lead to discrepancies between expected and observed PER2 phosphorylation patterns:

• Temporal considerations: PER2 phosphorylation varies throughout the circadian cycle. If samples are collected at different circadian times, patterns may appear inconsistent. The S662G mutation shifts the timing of maximal phosphorylation to CT20, compared to CT12 for wild-type PER2 .

• Subcellular fractionation issues: Since PER2 is predominantly nuclear, inadequate nuclear extraction or contamination between fractions can affect results . Human PER2 was found predominantly in nuclear fractions of liver extracts, with cytoplasmic PER2 being barely detectable in fibroblasts from both FASPS individuals and S662G transgenic mice .

• Phosphatase activity during sample preparation: Without proper phosphatase inhibitors, PER2 can be dephosphorylated during extraction. Treatment with phosphatase inhibitors (sodium vanadate) is essential to preserve phosphorylation status .

• Antibody specificity: The phospho-specific antibody might recognize other phosphorylated residues if they share sequence similarity with the S662 region. Verification with S662A mutants is important for confirming specificity .

• Stoichiometry of kinase-substrate interactions: The ratio of CK1δ/ε to PER2 can affect phosphorylation efficiency. Increasing CK1δ ΔC concentration by just 10-fold significantly altered phosphorylation of unprimed FASP-WT peptide .

How might new insights into PER2 phosphorylation inform therapeutic approaches for circadian disorders?

Understanding the molecular mechanisms of PER2 phosphorylation, particularly at S662, opens several therapeutic avenues for circadian disorders:

• Targeted kinase modulators: Developing compounds that specifically modulate CK1δ/ε activity toward S662 versus S480 could allow precise adjustment of circadian period. Since CK1δ/ε functions as both the priming kinase for S662 and the kinase responsible for downstream phosphorylation , targeted modulators could influence the phosphoswitch to address specific circadian abnormalities.

• Phosphatase regulators: Identifying and targeting phosphatases that dephosphorylate S662 could provide an alternative approach to modulating PER2 stability and function. The revised phosphoswitch model suggests that balance between kinase and phosphatase activities is crucial for normal circadian timing .

• PTM crosstalk interventions: Developing compounds that influence the interplay between phosphorylation, SUMOylation, and acetylation could offer novel therapeutic approaches. SUMO1 conjugation enhances CK1-mediated PER2 stability, while SUMO2 conjugation promotes degradation .

• Peptide-based therapeutics: Designing peptides that mimic the phosphorylated S662 region could potentially modulate PER2 interactions with regulatory proteins, offering a targeted approach to adjusting circadian parameters.

• Circadian phenotyping for personalized medicine: Using Phospho-PER2 (S662) Antibody in diagnostic applications could help categorize patients with circadian disorders based on their molecular phenotype, leading to more personalized therapeutic approaches.

What technical advances could improve the study of PER2 phosphorylation dynamics?

Several technological advances could significantly enhance our ability to study PER2 phosphorylation dynamics:

• Real-time phosphorylation sensors: Development of fluorescent biosensors that report on S662 phosphorylation status in living cells would allow dynamic monitoring of this critical modification throughout the circadian cycle.

• Mass spectrometry advances: Improved sensitivity in mass spectrometry techniques would enable more comprehensive analysis of PER2 phosphorylation patterns and their temporal dynamics, potentially revealing additional regulatory sites.

• Single-cell analysis methods: Technologies that enable assessment of PER2 phosphorylation in individual cells would reveal cell-to-cell variability in phosphorylation patterns and how this contributes to population-level circadian rhythms.

• Improved phospho-specific antibodies: Development of antibodies specific for multiple phosphorylation sites on PER2 would allow more comprehensive mapping of phosphorylation patterns and their relationships.

• CRISPR-based approaches: Precise genome editing to create endogenously tagged PER2 variants would enable more physiological studies of phosphorylation dynamics without overexpression artifacts.